Reacto and immunogenicity of an inactivated hepatitis A vaccine in children with chronic renal disease.

被引：0
|
作者：
Velasco, MCC
Mutti, J
Alvarez, K
Palti, G
Gonzalez, J
Exeni, R
Rüttimann, R
机构：
[1] Hosp Nino San Justo, Buenos Aires, DF, Argentina
[2] Inst Malbran, Buenos Aires, DF, Argentina
[3] GlaxoSmithKline, Buenos Aires, DF, Argentina
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1950
引用
收藏
页码：650A / 650A
页数：1
相关论文
共 50 条
  • [31] Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults
    Chen, XQ
    Bulbul, M
    deGast, GC
    vanLoon, AM
    Nalin, DR
    vanHattum, J
    JOURNAL OF HEPATOLOGY, 1997, 26 (02) : 260 - 264
  • [32] Does immunoglobulin interfere with the immunogenicity to Pasteur Merieux inactivated hepatitis A vaccine?
    Zanetti, A
    Pregliasco, F
    Andreassi, A
    Pozzi, A
    Vigano, P
    Cargnel, A
    Briantais, P
    Vidor, E
    JOURNAL OF HEPATOLOGY, 1997, 26 (01) : 25 - 30
  • [33] Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
    Weinstein, T
    Chagnac, A
    Boaz, M
    Ori, Y
    Herman, M
    Gafter, U
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 709A - 709A
  • [34] Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
    Xiang, Tiandan
    Liang, Boyun
    Wang, Hua
    Quan, Xufeng
    He, Shengsong
    Zhou, Helong
    He, Yongwen
    Yang, Dongliang
    Wang, Baoju
    Zheng, Xin
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (12) : 2679 - 2681
  • [35] Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
    Tiandan Xiang
    Boyun Liang
    Hua Wang
    Xufeng Quan
    Shengsong He
    Helong Zhou
    Yongwen He
    Dongliang Yang
    Baoju Wang
    Xin Zheng
    Cellular & Molecular Immunology, 2021, 18 : 2679 - 2681
  • [36] IMMUNOGENICITY, SAFETY AND TOLERABILITY OF VARYING DOSES AND REGIMENS OF INACTIVATED HEPATITIS-A VIRUS-VACCINE IN NAVAJO CHILDREN
    NEWCOMER, W
    RIVIN, B
    REID, R
    MOULTON, LH
    WOLFF, M
    CROLL, J
    JOHNSON, C
    BROWN, L
    NALIN, D
    SANTOSHAM, M
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) : 640 - 642
  • [37] SAFETY, TOLERABILITY AND IMMUNOGENICITY OF A FORMALIN-INACTIVATED HEPATITIS-A VACCINE (VAQTA(R)) IN RURAL KENTUCKY CHILDREN
    BLOCK, SL
    HEDRICK, JA
    TYLER, RD
    SMITH, RA
    CALANDRA, G
    PATTERSON, C
    LEWIS, J
    SITRIN, R
    MILLER, W
    SCHWARTZ, S
    WIENS, B
    NALIN, D
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (12) : 976 - 980
  • [38] Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years
    Fan, PC
    Chang, MH
    Lee, PI
    Safary, A
    Lee, CY
    VACCINE, 1998, 16 (2-3) : 232 - 235
  • [39] Inactivated hepatitis A vaccine in Chinese patients with chronic hepatitis B infection
    Tsang, SWC
    Sung, JJY
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (11) : 1445 - 1449
  • [40] Immunogenicity of hepatitis A vaccine in decompensated liver disease
    Dumot, JA
    Barnes, DS
    Younossi, Z
    Gordon, SM
    Avery, RK
    Domen, RE
    Henderson, JM
    Carey, WD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (06): : 1601 - 1604
12345